Skip to content

Clinical trials

Urogenital Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Country / region: Spain Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20181
20201
20221
20232
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Completed3
Active, not recruiting2
Approved for marketing1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Spanish Oncology Genito-Urinary Group2
Advanced Accelerator Applications1
Astellas Pharma Global Development, Inc.1
Atavistik Bio, Inc1
Eli Lilly and Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Marengo Therapeutics, Inc.1
Pfizer1
Steba Biotech S.A.1
University of Alicante1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms11
Prostatic Neoplasms8
Neoplasms6
Genital Neoplasms, Male5
Neoplasms by Site5
Genital Diseases, Male3
Prostatic Diseases3
Carcinoma2
Carcinoma, Renal Cell2
Endometrial Neoplasms2

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.